Suzhou Puhe Pharmaceutical Technology Co., LTD

Quick facts

Phase 3 pipeline

• Pemetrexed+carboplatin/Cisplatin · Oncology
  Pemetrexed inhibits multiple folate-dependent enzymes to disrupt DNA synthesis, while carboplatin or cisplatin cross-link DNA strands, together inducing cancer cell death.
• YK-209A tablet · Oncology
  YK-209A tablet is a small molecule that targets the PI3K/AKT signaling pathway.

Phase 1 pipeline

• PH009-1 tablet
• YK-029A

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Suzhou Puhe Pharmaceutical Technology Co., LTD portfolio CI brief
• Suzhou Puhe Pharmaceutical Technology Co., LTD pipeline updates RSS